background

Filter By Category

Active Pharma Ingredients
Disease Dictionary

Archives

Posted by -

Active Pharma Ingredients / 28 Aug 2026

ARNOLOL

Generic Name: ARNOLOL

ABSTRACT -

Arnolol is a beta-blocker type compound described as a pressure-lowering adrenergic antagonist. Publicly available modern clinical labeling is limited compared with widely marketed beta-blockers. It should be considered a specialist or region-specific agent unless a local approved label is available.

DOSAGE -

  • No universally established approved dosage could be confirmed from major current labels.
  • Any use should follow the country-specific product label and physician judgment.
  • Dosing should be individualized according to blood pressure, heart rate, arrhythmia/angina status, renal/hepatic function, and tolerability.
  • Do not stop beta-blocker therapy abruptly unless medically directed.

SIDE EFFECTS–

  • Bradycardia, hypotension, dizziness, fatigue, or cold extremities
  • Sleep disturbance, depression, or reduced exercise tolerance
  • Bronchospasm in asthma/COPD-prone patients
  • Nausea, diarrhea, or abdominal discomfort
  • Masking of hypoglycemia symptoms in diabetes
  • Rash or hypersensitivity reactions

ALLERGIC REACTIONS -

  • Allergy may present with rash, urticaria, facial swelling, wheezing, or anaphylaxis.
  • Severe reactions require discontinuation and urgent care.

DRUG INTERACTIONS–

  • Other beta-blockers, calcium-channel blockers such as verapamil/diltiazem, digoxin, amiodarone, and antiarrhythmics can increase bradycardia or AV block.
  • Antihypertensives, alcohol, anesthetics, and alpha blockers can increase hypotension.
  • Insulin and sulfonylureas may have masked hypoglycemia warning symptoms.
  • NSAIDs may reduce antihypertensive effect.

PREAUTIONS–

  • Assess asthma/COPD, heart block, bradycardia, decompensated heart failure, peripheral vascular disease, diabetes, thyroid disease, and pregnancy status.
  • Monitor pulse, blood pressure, ECG when indicated, respiratory symptoms, and glucose in diabetes.
  • Taper gradually when discontinuing chronic therapy.
  • Use cautiously in older adults and patients with conduction disease.

WARNINGS –

  • Contraindications may include severe bradycardia, cardiogenic shock, uncontrolled heart failure, and high-grade AV block unless paced.
  • Abrupt withdrawal may worsen angina or precipitate cardiac events.
  • Seek urgent care for syncope, severe shortness of breath, or chest pain.
  • Keep out of reach of children.

 

Have any questions? or Need help Contact us – 022 6163 6163 | support@medicus.com

CONTACT US

We're not around right now. But you can send us an email and we'll get back to you, asap.

Sending

©2026 Copyright. All rights reserved. Powered by . Developed by Hats-Off

Log in with your credentials

Forgot your details?

Feedback